CanaQuest President Interviewed by the Wall Street Analyzer
TORONTO, Jan. 21, 2021 — CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the "Company" or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to release a recent interview with company Co-founder and President, Paul Ramsay, on The Wall Street Analyzer, a multi-media financial research and publishing company reporting to the investment community on publicly held companies. It can be heard in full at:https://wallstreetanalyzer.com/2020/12/23/canaquest-medical-corp-otc-canqf/Highlights in the discussion include significant milestones achieved by the Company:The Announcement that The Journal of Neuroscience has published the findings of Western University’s research leading to the discovery of Mentabinol®, a patented THC based formulation & L-theanine - a safer alternative, for people who are taking THC for mental [...]